Fresh Tracks Therapeutics, Inc. Profile Avatar - Palmy Investing

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…

Biotechnology
US, Boulder [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of FRTX's Analysis
CIK: 819050 CUSIP: - ISIN: US10802T2042 LEI: - UEI: -
Secondary Listings
FRTX has no secondary listings inside our databases.